Enlivex Therapeutics Ltd. (TLV:ENLV)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
366.00
-12.70 (-3.35%)
Apr 1, 2025, 4:39 PM IDT

Enlivex Therapeutics Market Cap

Enlivex Therapeutics has a market cap or net worth of 79.44 million as of April 1, 2025. Its market cap has decreased by -72.72% in one year.

Market Cap
79.44M
Enterprise Value
-8.96M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
366.00

Market Cap Chart

Since March 26, 2019, Enlivex Therapeutics's market cap has decreased from 368.04M to 79.44M, a decrease of -78.42%. That is a compound annual growth rate of -22.51%.

History

DateMarket Cap% Change
Mar 28, 202582.88M-11.55%
Dec 31, 202493.71M-48.18%
Dec 29, 2023180.84M-29.06%
Dec 30, 2022254.92M-28.46%
Dec 31, 2021356.33M-8.65%
Dec 31, 2020390.07M30.23%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Teva Pharmaceutical Industries 63.85B
Danel (Adir Yeoshua) 2.16B
Kamada 1.46B
Bait Bakfar 897.25M
Novolog (Pharm-Up 1966) 845.44M
Ilex Medical 741.81M
BrainsWay 667.22M
SofWave Medical 555.35M
Market Cap Rankings